Dr. Lawrence Einhorn (left) led the medical team treating champion cyclist and testicular cancer survivor Lance Armstrong.

Thanks to a cure developed by Dr. Lawrence Einhorn, Distinguished Professor of Medicine, a diagnosis of testicular cancer no longer carries the death sentence it did just 30 years ago.

The most common cancer among young men, testicular cancer had a mortality rate of 90 percent in the early 1970s, when Einhorn was a young oncologist at the IU School of Medicine. In 1974, he developed a chemotherapy regimen to treat the disease and turn that mortality rate upside down—the survival rate is currently 95 percent overall. His innovation established Indiana University as the leading testicular cancer treatment center in the United States. Notably, Einhorn led the medical team treating testicular cancer survivor Lance Armstrong, Olympic cyclist and seven-time Tour de France champion.

The story doesn’t end here. An internationally recognized authority on other types of urologic cancer, lung cancer, and certain other tumors, Einhorn is widely praised as an educator of future physicians and received IU’s oldest teaching award, the Frederic Bachman Lieber Memorial Award, in 2000. Valued for his generous mentoring skills and passion for the field, Einhorn has inspired an unusual number of IU School of Medicine students to specialize in oncology.

Einhorn’s academic honors are many, including membership in the National Academy of Sciences and the American Philosophical Society, and Fellow, American College of Physicians.